Intravenous Thrombolytic Therapy in Acute Stroke: Frequent Systemic Problems and Solutions
Journal Title: UNKNOWN - Year 2018, Vol 24, Issue 1
Abstract
One of the most important reasons why the use of the intravenous (IV) tissue plasminogen activator (tPA), which is one of the key elements of acute ischemic stroke treatment, is not sufficiently widespread is the fact that many common questions have not been adequately answered. In this review, questions about systemic nonneurologic conditions, problems related with IV tPA treatment and complications of treatment, which were collected from our colleagues practicing in Turkey and which are more important in clinical practice, were answered on the basis of the current literature and clear recommendations are made.
Authors and Affiliations
Mehmet Akif Topçuoğlu, Ethem Murat Arsava, Atilla Özcan Özdemir, Erdem Gürkaş, Dilek Necioğlu Örken, Şerefnur Öztürk
Keywords
Related Articles
- EP ID EP276903
- DOI 10.4274/tnd.01212
- Views 93
- Downloads 0
Efficacy of Telerehabilitation in Patients with Stroke in Turkey: A Pilot Study
Objective: Telerehabilitation (TR) is not used very widely in our country. Our study was planned to evaluate the usefulness and effect of TR in patients with hemiplegia. Materials and Methods: The study was performed at...
Juvenile Neuronal Ceroid Lipofuscinoses: A Rare Case
.
Evaluation of Inflammation with Neutrophil-to-lymphocyte Ratio and Platelet-to-lymphocyte Ratio in Restless Legs Syndrome
Objective: Restless legs syndrome (RLS) is a chronic, progressive sensorimotor disorder characterized by an irresistible urge to move the extremities-especially the legs-and abnormal sensations. Although symptoms are obs...
Clinical Features of Cerebral Venous Sinus Thrombosis
Objective: To investigate the predisposing factors for cerebral venous sinus thrombosis (CVST), presenting patterns of the disease, imaging characteristics, types of treatment, and outcomes of patients. Materials and Met...
Flow Cytometry Analysis of Peripheral Blood B Cell Distribution of Patients with Multiple Sclerosis
Objective: Multiple sclerosis (MS) is a central nervous system (CNS) disease characterized by autoimmune inflammation and neurodegeneration. Damage to the CNS is thought to be mediated predominantly by activated pro-infl...